Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium
Li Rita Zhang,Hal Morgenstern,Sander Greenland,Shen Chih Chang,Philip Lazarus,M. Dawn Teare,Penella J. Woll,Irene Orlow,Brian Cox,Yonathan Brhane,Geoffrey Liu,Rayjean J. Hung +11 more
Reads0
Chats0
TLDR
Results from the pooled analyses provide little evidence for an increased risk of lung cancer among habitual or long‐term cannabis smokers, although the possibility of potential adverse effect for heavy consumption cannot be excluded.Abstract:
To investigate the association between cannabis smoking and lung cancer risk, data on 2,159 lung cancer cases and 2,985 controls were pooled from 6 case-control studies in the US, Canada, UK, and New Zealand within the International Lung Cancer Consortium. Study-specific associations between cannabis smoking and lung cancer were estimated using unconditional logistic regression adjusting for sociodemographic factors, tobacco smoking status and pack-years; odds-ratio estimates were pooled using random effects models. Subgroup analyses were done for sex, histology and tobacco smoking status. The shapes of dose-response associations were examined using restricted cubic spline regression. The overall pooled OR for habitual versus nonhabitual or never users was 0.96 (95% CI: 0.66-1.38). Compared to nonhabitual or never users, the summary OR was 0.88 (95%CI: 0.63-1.24) for individuals who smoked 1 or more joint-equivalents of cannabis per day and 0.94 (95%CI: 0.67-1.32) for those consumed at least 10 joint-years. For adenocarcinoma cases the ORs were 1.73 (95%CI: 0.75-4.00) and 1.74 (95%CI: 0.85-3.55), respectively. However, no association was found for the squamous cell carcinoma based on small numbers. Weak associations between cannabis smoking and lung cancer were observed in never tobacco smokers. Spline modeling indicated a weak positive monotonic association between cumulative cannabis use and lung cancer, but precision was low at high exposure levels. Results from our pooled analyses provide little evidence for an increased risk of lung cancer among habitual or long-term cannabis smokers, although the possibility of potential adverse effect for heavy consumption cannot be excluded.read more
Citations
More filters
Book ChapterDOI
Routes of Administration, Pharmacokinetics and Safety of Medicinal Cannabis
Kylie O’Brien,Philip Blair +1 more
TL;DR: There are four main routes of administration of medicinal cannabis: inhalation, the oral route, topical applications and ‘other routes’ (eg. suppositories, intranasal delivery). Each is associated with different onsets of action and durations of action due to their pharmacokinetic profiles.
Journal ArticleDOI
Précarité sociale et socio-culturelle : impact sur les traitements et accès à l’innovation thérapeutique
Alice Mogenet,Pascale Tomasini +1 more
TL;DR: In this article , Masson et al. pointed out that social precarity is associated with a higher prevalence of risk factors such as the use of tobacco and cannabis, and that the adhesion of underprivileged patients to screening programs being established in France is poor.
Book ChapterDOI
Cannabiskonsum zum Freizeitgebrauch
Miriam Schneider,Chris Maria Friemel,Rupert von Keller,Kristina Adorjan,Udo Bonnet,Alkomiet Hasan,Derik Hermann,Joseph Kambeitz,Dagmar Koethe,Ludwig Kraus,F. Markus Leweke,Beat Lutz,Liane D. Paul,Oliver Pogarell,Ulrich W. Preuss,Michael Schäfer,Sophia Schmieder,Roland Simon,Martin Storr,Eva Hoch +19 more
TL;DR: In this paper, weiß man dabei eine Vielzahl bewusster sowie unbewusster neuronaler Prozesse des Gehirns, die bei der Verarbeitung externer und interner Informationen ablaufen.
References
More filters
Journal ArticleDOI
Measuring inconsistency in meta-analyses
TL;DR: A new quantity is developed, I 2, which the authors believe gives a better measure of the consistency between trials in a meta-analysis, which is susceptible to the number of trials included in the meta- analysis.
Book
Cancer Epidemiology and Prevention
TL;DR: This is an account of cancer epidemiology has been expanded and contains new material on cancer biology, molecular epidemiology, preventive strategies and specific types and sites of cancer.
European Monitoring Centre for Drugs and Drug Addiction
TL;DR: The EMCDDA Programme 2, 'Analysis of responses', set out to identify how social reintegration is understood in each Member State and to map the availability of social reIntegration facilities in Member States according to these national perceptions.
Tobacco smoke and involuntary smoking
Michael C. R. Alavanja,John A. Baron,Ross C. Brownson,Patricia A. Buffler,David M. DeMarini,Mirjana V. Djordjevic,Richard Doll,Elizabeth T. H. Fontham,Yu-Tang Gao,Nigel Gray,Prakash C. Gupta,A. K. Hackshaw,Stephen S. Hecht,Kirsti Husgafvel-Pursiainen,Elena Matos,Richard Peto,David H. Phillips,Jonathan M. Samet,Gary D. Stoner,Michael J. Thun,Jean Trédaniel,Paolo Vineis,H.-Erich Wichmann,Anna H. Wu,David Zaridze +24 more